Compositions and methods for generating immunity to bacterial infection
AssigneeSyntiron LLC
InventorsLeah Randles, Lisa Herron-Olson, Patricia Ellen Tam
Life of this patent
Estimating the term…
Loading patent…
AssigneeSyntiron LLC
InventorsLeah Randles, Lisa Herron-Olson, Patricia Ellen Tam
Estimating the term…
The present disclosure relates, in part, to a polypeptide of formula (I), or a salt or solvate thereof, and a vaccine composition thereof further comprising at least one pharmaceutically acceptable excipient. The present disclosure further relates to isolated mRNA and/or isolated polynucleotides encoding the polypeptide of formula (I), vectors and/or LNPs comprising the same, and pharmaceutical compositions thereof. The present disclosure further relates to methods of treating, preventing, and/or ameliorating a bacterial infection, and/or generating immunity to infection by one or more pathogenic bacteria, in a subject in need thereof, the method comprising administering to the subject at least one composition of the present disclosure. In certain embodiments, the bacterial infection is a urinary tract infection, sepsis (e.g., neonatal sepsis), or pneumonia.
A 1 tide comprising formula (I), or a salt or solvate thereof:
(canceled)
(canceled)
(canceled)
12-14. (canceled)
A polypeptide selected from the group consisting of:
17-26. (canceled)
29-53. (canceled)
55-56. (canceled)
64-69. (canceled)
71-72. (canceled)
77-82. (canceled)
84-85. (canceled)
Dependencies are inferred from the claim text.